Tijori
Caplin Point Laboratories Limited
Market Capital
₹ 2,084 Cr.
P/E
9.65
Share Price
₹277.80 -4.60 (-1.63%)
  • Caplin Point Laboratories Limited
  • Overview
  • Connections
  • Financials
  • Shareholding
  • Pharma Sector

  • Revenue Mix
  • Operational Metrics

  • Competitors
  • Investors

  • Price
  • Benchmarking
  • Balance Sheet
  • Profit & Loss
  • Cash Flows
  • Ratios
  • Quarterly Results

  • Overview
  • Trend
  • Detailed

  • Recent News
  • Annual Reports

Revenue Mix
Product Break-Up
Location Wise Break-Up
Operational Metrics for Caplin Point Lab
0.70% (as of Mar 19)
Change in PAT with 1% Appreciation in FX Basket
0.31% (as of Mar 19)
Management Compensation as a % of Sales
Pharmaceuticals
10.87% (as of Mar 19)
R&D as a % of Total Sales
12 (as of Mar 19)
Number of ANDA's Filed in USA
6 (as of Mar 19)
Number of ANDA's Approved By USFDA
Compare with Competitors


Competitors
Peer Name Market Cap.
Caplin Point Laboratories Limited 2,084
Shilpa Medicare Limited 2,093
Claris Lifesciences Limited 2,164
Wockhardt Limited 1,970
Sequent Scientific Limited 1,817
Indoco Remedies Limited 1,816
Novartis India Ltd 1,704
Thyrocare Technologies Limited 2,639
Strides Pharma Science Limited 2,923
Aarti Drugs Limited 1,206
IOL Chemicals and Pharmaceuticals Limited 1,195
Unichem Laboratories Limited 1,012
Alembic Limited 937
TTK Healthcare Limited 919
Dishman Carbogen Amics Limited 884
FDC Limited 3,318
Hikal Limited 848
Astec LifeSciences Limited 779
Newgen Software Technologies Ltd. 742
Laurus Labs 3,458
Panacea Biotec Limited 698
Healthcare Global Enterprises Limited 647
Medicamen Biotech Limited 633
Gufic Biosciences Limited 630
Granules India Limited 3,593
Morepen Laboratories Limited 435
Neuland Laboratories Limited 353
Anuh Pharma Limited 341
Sun Pharma Advanced Research Company Limited 3,838
Bajaj Healthcare Limited 288
JK Agri Genetics Limited 287
JB Chemicals & Pharmaceuticals Limited 3,901
Suven Life Sciences Limited 259
Albert David Limited 247
Jenburkt Pharma Limited 243
Nectar Lifesciences Limited 230
Themis Medicare Limited 213
Wintac Limited 199
Fredun Pharmaceuticals Limited 172
Everest Organics Limited 147
Ambalal Sarabhai Enterprises Limited 140
Kabra Extrusion Technik Limited 136
Dr Agarwals Eye Hospital Ltd. 133
Ind-Swift Laboratories Limited 132
Coral Lab 96
Zim Laboratories Limited 92
Bharat Parenterals Limited 79
Vivimed Labs Limited 62
Zota Healthcare Limited 0
Jubilant Life Sciences Limited 4,258
Eris Lifesciences 5,001
Narayana Hrudayalaya Ltd 5,129
Glenmark Pharmaceuticals Limited 5,753
Natco Pharma Limited 9,061
Fortis Healthcare Limited 9,139
Alembic Pharmaceuticals Limited 10,147
Ajanta Pharma Limited 11,904
IPCA Laboratories Limited 17,622
Hindustan Aeronautics Limited 17,813
Pfizer Limited 18,163
GlaxoSmithKline Pharmaceuticals Limited 20,496
Piramal Enterprises Limited 21,117
Aurobindo Pharma Limited 22,978
Lupin Limited 26,238
Cadila Healthcare Limited 27,011
Alkem Laboratories Limited 27,198
Torrent Pharmaceuticals Limited 33,173
Cipla Limited 33,342
Divi's Laboratories Limited 49,948
Dr. Reddy's Laboratories Limited 51,450
Sun Pharmaceuticals Industries Limited 82,429
Show More
Peer Name Market Cap.
Caplin Point Laboratories Limited 2,084
Shilpa Medicare Limited 2,093
Sequent Scientific Limited 1,817
Indoco Remedies Limited 1,816
Aarti Drugs Limited 1,206
Unichem Laboratories Limited 1,012
FDC Limited 3,318
Panacea Biotec Limited 698
Morepen Laboratories Limited 435
Bajaj Healthcare Limited 288
RPG Life Sciences Limited 285
JB Chemicals & Pharmaceuticals Limited 3,901
Wintac Limited 199
Kopran Limited 100
Vivimed Labs Limited 62
Bal Pharma Limited 45
Jubilant Life Sciences Limited 4,258
Glenmark Pharmaceuticals Limited 5,753
Natco Pharma Limited 9,061
Alembic Pharmaceuticals Limited 10,147
IPCA Laboratories Limited 17,622
Aurobindo Pharma Limited 22,978
Lupin Limited 26,238
Cadila Healthcare Limited 27,011
Torrent Pharmaceuticals Limited 33,173
Biocon Limited 33,396
Divi's Laboratories Limited 49,948
Sun Pharmaceuticals Industries Limited 82,429
Show More
Investors
Price
277.80 -4.60 (-1.63%)
Benchmarking
269
Balance Sheet
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Profit & Loss
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Cash Flow
  • Standalone
  • Consolidated
(in Rs. Cr.) Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Ratios
= Dominant Factor
(in Rs. Cr.) Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019